Pharmaceutical
Protection that powers progress
Artificial intelligence is revolutionizing drug development, clinical trials, and manufacturing optimization. Our expert brokers can help you protect against new data and IP risks.
As major patents expire, generics manufacturers can step in. We help you navigate patent cliffs and market transitions with strategic risk management that protects your portfolio.
Evolving regulations around drug pricing, trade agreements, and market access are reshaping competition. We can help you unlock new markets and strengthen your position.
Manufacturing capabilities are relocating to strengthen supply chains and meet regional regulatory requirements. Protect every part of the process and stay compliant with our local experts and global reach.
Supply chains are complex and fragile. Disruptions can halt production and delay critical treatments. You need a partner who understands these vulnerabilities and can help you build resilience across every link in the chain.
Multi-market approvals and evolving regulations make clinical trials riskier than ever. A single compliance failure or trial delay can cost millions. With our specialist coverage and guidance, you can navigate this complexity with confidence.
Digitization and AI bring new threats, including sophisticated cyberattacks, data breaches, and IP theft. WBN provides robust protection for your research data, manufacturing systems, and patient information.
We understand the high stakes of pharmaceutical innovation. That's why we build coverage that keeps your innovation and operations resilient. Our global network provides comprehensive solutions across your entire value chain — from protecting your drug development investments to ensuring regulatory compliance in every market.